Pfizer launches Phase I trial of new oral COVID-19 treatmentThis is the first orally administered coronavirus-specific investigational protease inhibitor to be evaluated in clinical studies.A refrigerated truck leaves the Pfizer plant in Puurs, Belgium December 3, 2020. (photo credit: YVES HERMAN/REUTERS)
